Dybbs Michael

CIK 00016012645 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001601264

Recent Transactions

23 trades

Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2025-06-06+50,000→ 50,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2025-06-05+46,000→ 46,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2025-04-10+18,000→ 18,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2024-06-13+22,500→ 22,500 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2024-06-06+35,000→ 35,000 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2023-06-08+25,000→ 25,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2023-06-07+22,500→ 22,500 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2022-06-08+16,000→ 16,000 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2022-06-06+18,500→ 18,500 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2021-06-13+16,511→ 16,511 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2021-06-03+18,500→ 18,500 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2020-07-09+10,700→ 10,700 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy)
2020-06-05+12,000→ 12,000 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy Common Stock)
2019-06-17+11,610→ 11,610 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy Common Stock)
2018-09-26+26,033→ 26,033 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−32,069→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−17,000→ 0 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-05-25+17,000→ 17,000 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2016-05-19+32,069→ 32,069 total
Purchase
Dimension Therapeutics, Inc.
Common Stock
2015-10-27$13.00/sh+961,538→ 2,059,283 total
Conversion
Dimension Therapeutics, Inc.
Series B Preferred Stock
2015-10-27−3,208,711→ 0 total
Conversion
Dimension Therapeutics, Inc.
Common Stock
2015-10-27+1,097,745→ 1,097,745 total
Award
Aravive, Inc.
Stock Option (Right to Buy)
2014-03-20+35,000→ 35,000 total

Dybbs Michael

Recent Transactions

Companies

Recent Filings

Address